1. Home
  2. PDSB vs ICCM Comparison

PDSB vs ICCM Comparison

Compare PDSB & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.88

Market Cap

49.5M

Sector

Health Care

ML Signal

HOLD

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$0.66

Market Cap

45.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDSB
ICCM
Founded
2005
2006
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.5M
45.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PDSB
ICCM
Price
$0.88
$0.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$9.00
$2.50
AVG Volume (30 Days)
592.3K
353.1K
Earning Date
11-13-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,975,000.00
Revenue This Year
N/A
$13.67
Revenue Next Year
N/A
$38.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$0.59
52 Week High
$2.20
$1.66

Technical Indicators

Market Signals
Indicator
PDSB
ICCM
Relative Strength Index (RSI) 49.68 43.85
Support Level $0.86 $0.65
Resistance Level $0.93 $0.68
Average True Range (ATR) 0.07 0.03
MACD -0.00 0.00
Stochastic Oscillator 11.26 46.72

Price Performance

Historical Comparison
PDSB
ICCM

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: